Superworth

Strata Critical Medical price to sales ratio SRTA

Market value divided by revenue over the last twelve months, since 2022.

Today, Nov 2, 2026
1.5×
4-year median
1.5×
Against its 4-year history
50th
percentile: 0 is its lowest day, 100 its highest
4-year range
0.8× to 6.2×
Peer median
0.7×

Strata Critical Medical's price to sales ratio is 1.5× as of Nov 2, 2026.

That is above its 4-year median of 1.5×, close to the middle of its last 4 years.

Over that time it ranged from 0.8× in Apr 2025 to 6.2× in May 2022.

The median for 5 travel stocks of a similar size is 0.7×.

Price to sales ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far1.5×1.5×2.3×
20251.8×0.8×1.9×
20241.4×0.9×1.5×
20231.2×0.8×2.6×
20221.9×1.9×6.2×

Against its peers

Companies in Travel Services nearest Strata Critical Medical's size, closest first, today.

CompanyPrice to sales ratio
SRTAStrata Critical Medical1.5×
VRRMVERRA MOBILITY0.4×
PANLPangaea Logistics Solutions0.7×
GNKGenco Shipping & Trading2.4×
LPGDorian LPG3.7×
ABMABM Industries0.3×
Peer median0.7×

Where Strata Critical Medical ranks

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on Strata Critical Medical

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.